CMO
Technology transfer and manufacturing from the client’s dossier.
COMPANY OVERVIEW · SEPTEMBER 2026
From formulation challenge to manufacturing programme.
Sikalias Pharmaceutical Laboratories SA · Two complementary manufacturing sites in Peristeri, Athens.
Four routes to collaboration
CDMO
Development, technical documentation and subsequent manufacturing, with an agreed regulatory pathway.
R&D materials
Project-based evaluation of APIs, excipients, extracts and functional ingredients.
Nearshoring
A European base for complex-molecule and biotech startup programmes: drug-product development, transfer and non-sterile manufacturing assessment.
Explore the approach →Technical platform
Non-sterile oral liquids, topical and semisolid products, sprays and drops, hard capsules, tablets and powders. Low-humidity room below 10% RH, nitrogen capability on selected liquid lines, and integrated production and packaging flows.
Quality & qualification
Project-specific site selection, authorisation scope, technical transfer, stability and validation planning. QA provides the controlled quality package. Site 1 now also has GMP certification; QA provides the current site-specific certificate, authorisations and exact scope for project qualification.
Quality documentationContinue the conversation
info@sikalias.com · +30 210 572 0900 · https://sikalias.com/partners/
Site 0: 7 Kyklaminon str., Ag.Ierotheos, Peristeri, 12137, Greece
Site 1: 3–5 Stilianou Gonata str., Peristeri Industrial Park, 12133, Greece